Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A New Class of 1-Aryl-5,6-dihydropyrrolo[2,1-a]isoquinoline Derivatives as Reversers of P-Glycoprotein-Mediated Multidrug Resistance in Tumor Cells.
Nevskaya AA, Matveeva MD, Borisova TN, Niso M, Colabufo NA, Boccarelli A, Purgatorio R, de Candia M, Cellamare S, Voskressensky LG, Altomare CD. Nevskaya AA, et al. Among authors: boccarelli a. ChemMedChem. 2018 Aug 10;13(15):1588-1596. doi: 10.1002/cmdc.201800177. Epub 2018 Jul 4. ChemMedChem. 2018. PMID: 29802687
Chemical and Biological Evaluation of Novel 1H-Chromeno[3,2-c]pyridine Derivatives as MAO Inhibitors Endowed with Potential Anticancer Activity.
Kulikova LN, Purgatorio R, Beloglazkin AA, Tafeenko VA, Reza RG, Levickaya DD, Sblano S, Boccarelli A, de Candia M, Catto M, Voskressensky LG, Altomare CD. Kulikova LN, et al. Among authors: boccarelli a. Int J Mol Sci. 2023 Apr 23;24(9):7724. doi: 10.3390/ijms24097724. Int J Mol Sci. 2023. PMID: 37175433 Free PMC article.
A second life for MAO inhibitors? From CNS diseases to anticancer therapy.
Sblano S, Boccarelli A, Mesiti F, Purgatorio R, de Candia M, Catto M, Altomare CD. Sblano S, et al. Among authors: boccarelli a. Eur J Med Chem. 2024 Mar 5;267:116180. doi: 10.1016/j.ejmech.2024.116180. Epub 2024 Jan 24. Eur J Med Chem. 2024. PMID: 38290352 Free article. Review.
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability.
Pati ML, Vitale P, Ferorelli S, Iaselli M, Miciaccia M, Boccarelli A, Di Mauro GD, Fortuna CG, Souza Domingos TF, Rodrigues Pereira da Silva LC, de Pádula M, Cabral LM, Sathler PC, Vacca A, Scilimati A, Perrone MG. Pati ML, et al. Among authors: boccarelli a. Eur J Med Chem. 2019 Feb 15;164:59-76. doi: 10.1016/j.ejmech.2018.12.029. Epub 2018 Dec 15. Eur J Med Chem. 2019. PMID: 30590258
40 results